ZA839258B - Pyrazolo(4,3-b)(1,4)oxazines,a process for their preparation and their use as medicaments - Google Patents

Pyrazolo(4,3-b)(1,4)oxazines,a process for their preparation and their use as medicaments

Info

Publication number
ZA839258B
ZA839258B ZA839258A ZA839258A ZA839258B ZA 839258 B ZA839258 B ZA 839258B ZA 839258 A ZA839258 A ZA 839258A ZA 839258 A ZA839258 A ZA 839258A ZA 839258 B ZA839258 B ZA 839258B
Authority
ZA
South Africa
Prior art keywords
oxazines
pyrazolo
medicaments
preparation
Prior art date
Application number
ZA839258A
Inventor
Romanis Fruchtmann
Harald Horstmann
Mardin Mithat
Wolfgang Opitz
Bernhard Pelster
Siegfried Raddatz
Original Assignee
Troponwerke Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Gmbh & Co Kg filed Critical Troponwerke Gmbh & Co Kg
Publication of ZA839258B publication Critical patent/ZA839258B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA839258A 1982-12-14 1983-12-13 Pyrazolo(4,3-b)(1,4)oxazines,a process for their preparation and their use as medicaments ZA839258B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823246148 DE3246148A1 (en) 1982-12-14 1982-12-14 Pyrazolo[4,3-b][1,4]-oxazines, process for their preparation and their use as medicaments

Publications (1)

Publication Number Publication Date
ZA839258B true ZA839258B (en) 1984-08-29

Family

ID=6180567

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA839258A ZA839258B (en) 1982-12-14 1983-12-13 Pyrazolo(4,3-b)(1,4)oxazines,a process for their preparation and their use as medicaments

Country Status (4)

Country Link
JP (1) JPS59116288A (en)
KR (1) KR840007006A (en)
DE (1) DE3246148A1 (en)
ZA (1) ZA839258B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2264685C (en) 1996-08-27 2002-10-15 Kyoji Noda 2-phenylmorpholin-5-one derivatives and pharmaceutical composition comprising the same
JO2998B1 (en) 2010-06-04 2016-09-05 Amgen Inc Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
US9376425B2 (en) 2011-09-27 2016-06-28 Amgen, Inc. Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
CA2901696C (en) * 2013-02-19 2021-04-13 Amgen Inc. Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer
US11407721B2 (en) 2013-02-19 2022-08-09 Amgen Inc. CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
WO2014134201A1 (en) 2013-02-28 2014-09-04 Amgen Inc. A benzoic acid derivative mdm2 inhibitor for the treatment of cancer
CA2906538C (en) 2013-03-14 2021-02-02 Ana Gonzalez Buenrostro Heteroaryl acid morpholinone compounds as mdm2 inhibitors for the treatment of cancer
JOP20200296A1 (en) 2013-06-10 2017-06-16 Amgen Inc Processes of Making and Crystalline Forms of a MDM2 Inhibitor

Also Published As

Publication number Publication date
JPS59116288A (en) 1984-07-05
DE3246148A1 (en) 1984-06-14
KR840007006A (en) 1984-12-04

Similar Documents

Publication Publication Date Title
ZA83743B (en) Pyrazolooxazines,pyrazolothiazines,and pyrazoloquinolines,process for their preparation and their use as medicaments
PT72370A (en) Process for preparing imidazo/1,2-a/piridines
IL67823A0 (en) Fibrinogen formulation,a process for its preparation and its use
ZA898858B (en) New quinuclidines,their use as medicaments and processes for their preparation
DE3377795D1 (en) Spergualin-related compounds, processes for the preparation thereof and their use as medicaments
ZA875043B (en) 7-acyloxy-6-aminoacyloxypolyoxylabdanes,a process for their preparation,and their use as medicaments
ZA813002B (en) Substituted trcyclic thieno compounds,processes for their preparation,their use and medicaments containing them
ZA839258B (en) Pyrazolo(4,3-b)(1,4)oxazines,a process for their preparation and their use as medicaments
ZA835673B (en) Fused 4h-1,4-benzothiazines,processes for their preparation,and their use as medicaments
DE3364376D1 (en) Isoindolazines, process for their preparation and their use
EG18059A (en) Process for the preparation(1)-1b-ethyl-1 & hydroxymethyl-1,2,3,4,6,7,12,12,bx-octahydroindolo(2,3-a)quinolizine
ZA869612B (en) 6h-isoxazol(5,4-d)pyrazolo(3,4-b)pyridines,a process and intermediates for their preparation and their use as medicaments
ZA906447B (en) Pyrido(3,4-b)(1,4)benzoxazepines,a process for their preparation and their use as medicaments
IL64907A0 (en) Tricyclic pyrroles,a process for their preparation,their use,and medicaments containing them
GB2051054B (en) Pyrazolo (1,5-c) quinazoline derivatives and a process for the preparation thereof
ZA856775B (en) Histargin-related compounds,a process for their preparation and their use as medicaments
DE3375576D1 (en) Cis-4a-aryl-1,2,3,4,4a,9b-hexahydro-benzofuro(3,2-c)pyridines, a process for preparing the same, and their use as medicaments
ZA825239B (en) Oxothienobenzoxepins,a method for their preparation and their use as medicaments
PT71177A (en) Process for preparing 3-substituted imidazo (1,2-a) piridines
ZA827368B (en) Substituted 6-phenoxypyrid-2-ylmethyl-vinylcyclopropanecarboxylates,a process for their preparation,and their use as pest-combating agents
IL60761A (en) Pyrimido benzodiazepinones,a process for their preparation and medicaments containing them
ZA913534B (en) Pyrrolo(2,3-b)indole-ketones and analogs,a process for their preparation and their use as medicaments
HUT34477A (en) Process for preparing pyrido/1,4/-benzodiazepines
ZA831706B (en) New carbacyclins,process for their preparation,and their use as medicaments
ZA832069B (en) 7-a-aminoacyl-3-chlorocephalosporins,process for their preparation and their use as medicaments